Skip to content

ROLE OF MUSICAL THERAPY COMBINED WITH SUFENTANIL FOR POSTOPERATIVE INTRAVENOUS ANALGESIA IN PATIENTS UNDERGOING LUNG CANCER RESECTION

ROLE OF MUSICAL THERAPY COMBINED WITH SUFENTANIL FOR POSTOPERATIVE INTRAVENOUS ANALGESIA IN PATIENTS UNDERGOING LUNG CANCER RESECTION

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003761
Enrollment
Unknown
Registered
2013-10-30
Start date
2013-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer Resection patient

Interventions

musical therapy group (group M) and control group:musical therapy

Sponsors

Hunan provincial Tumor Hospital (The Affiliated Tumor Hospital of Xiangya Medical school of Central South University)
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
35 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1)60 ASA I~II lung cancer patients, all patients underwent postoperative patient-controlled analgesia (PCA) with senfentanil.2)

Exclusion criteria

Exclusion criteria: allergic to any research drug, blood coagulation dysfunction, asthma, peptic ulcers, liver and kidney disease, hearing impairment, alcohol or drug abuse history, any known mental illness or memory dysfunction, inability to operate PCA and professional music background and severe high blood pressure and heart disease.

Design outcomes

Primary

MeasureTime frame
Visual analogue score;BP and H;

Countries

China

Contacts

Public ContactLiu Jingshi
743655404@qq.com+86 13875918968

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026